<p>最近的数据分析揭穿了竞争对手发布的不准确基准，SkylineDx 的独立分析显示，Merlin CP-GEP 测试在转移风险分层和对 SLNB 结果的预测准确性方面，优于 31-GEP/i31-SLNB 方法。这是通过全面评估发现的...</p>

<p>最近的数据分析揭穿了竞争对手发布的不准确基准，SkylineDx 的独立分析显示，Merlin CP-GEP 测试在转移风险分层和对 SLNB 结果的预测准确性方面，优于 31-GEP/i31-SLNB 方法。这是通过全面评估发现的……</p>

<p>Recent data analysis has debunked inaccurate benchmarks released by a competitor, with SkylineDx's separate analysis showcasing that the Merlin CP-GEP Test offers more robust metastatic-risk stratification and better predictive accuracy for SLNB outcomes compared to the 31-GEP/i31-SLNB method. This was found through a comprehensive evaluation...</p>
<div class="lb-trans"><p>最近的数据分析揭穿了竞争对手发布的不准确基准，SkylineDx 的独立分析显示，Merlin CP-GEP 测试在转移风险分层和对 SLNB 结果的预测准确性方面，优于 31-GEP/i31-SLNB 方法。这是通过全面评估发现的...</p>
</div>

SkylineDx 的 Merlin CP-GEP 测试在黑色素瘤风险分层方面优于竞争对手测试，显示出对 SLNB 结果更高的预测准确性